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Adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) is a
novel intracellularproteinwith50%protein identity toadenosyl-
homocysteinehydrolase (AHCY), an importantenzyme formetab-
olizing S-adenosyl-L-homocysteine, the by-product of S-adenosyl-
L-homomethionine-dependentmethylation.AHCYL1binds to the
inositol 1,4,5-trisphosphate receptor, suggesting that AHCYL1 is
involved in intracellular calcium release. We identified two
zebrafishAHCYL1orthologs (zAHCYL1Aand-B)bybioinformat-
ics and reverse transcription-PCR.Unlike theubiquitously present
AHCYgenes,AHCYL1geneswereonlydetected insegmentedani-
mals, andAHCYL1proteinswerehighly conservedamong species.
Phylogenic analysis suggested that the AHCYL1 gene diverged
early fromAHCYandevolved independently.Quantitative reverse
transcription-PCRshowed that zAHCYL1Aand -BmRNAexpres-
sion was regulated differently from the other AHCY-like protein
zAHCYL2 and zAHCY during zebrafish embryogenesis. Injection
ofmorpholino antisense oligonucleotides against zAHCYL1A and
-B into zebrafish embryos inhibited zAHCYL1A and -B mRNA
translation specifically and induced ventralized morphologies.
Conversely, humanandzebrafishAHCYL1AmRNAinjection into
zebrafish embryos induced dorsalized morphologies that were
similar to those obtained by depleting intracellular calcium with
thapsigargin. Human AHCY mRNA injection showed little effect
on the embryos. These data suggest that AHCYL1 has a different
functionfromAHCYandplaysanimportantrole inembryogenesis
by modulating inositol 1,4,5-trisphosphate receptor function for
the intracellular calcium release.
Wediscovered human adenosylhomocysteine hydrolase-like
protein 1 (hAHCYL12; previously termed dendritic cell-ex-
pressed AHCY-like protein, or DCAL) by differential display
from the Hodgkin disease-derived cell line L428 (1). The hAH-
CYL1 protein (60 kDa, 530 amino acids) consists of a novel
N-terminal hydrophilic domain (106 amino acids) and a C-ter-
minal domain (424 amino acids), which is homologous (51%
protein identity) to the methylation pathway enzyme, AHCY
(EC 3.3.1.1, 46 kDa). AHCY is the evolutionarily conserved
and ubiquitously expressed enzyme that catalyzes the reversi-
ble hydrolysis of S-adenosyl-L-homocysteine, a byproduct of
the S-adenosyl-L-homomethionine-dependent methyltrans-
ferase reaction, into adenosine and homocysteine using NAD
as a cofactor (2). Although AHCYL1 conserves the cysteines
required for a tight globular structure of AHCY and the NAD
binding motif, AHCYL1 lacks some binding sites for S-adeno-
syl-L-homocysteine, suggesting that AHCYL1 has a different
function from AHCY. The N-terminal hydrophilic domain
contains 79 polar or charged amino acids, including a cluster of
Ser, Thr, and Tyr (potential phosphorylation sites), and this
domain is likely to regulate AHCYL1 function (1).
AHCYL1 is highly conserved among species, and the human
and mouse orthologs have 100% protein identity, suggesting a
highly conserved function yet to be understood. The other
AHCY-like protein KIAA0828 (termedAHCYL2 hereafter) has
similar gene and protein structure to those of AHCYL1, but
again its function is unknown (1, 3). In blood, hAHCYL1mRNA
was predominantly expressed in dendritic cells (DC), the
most potent antigen-presenting cells for eliciting immune
responses (4, 5), but not in other leukocytes. Increased hAH-
CYL1 mRNA expression during DC differentiation and acti-
vation suggested that hAHCYL1 plays a role in DC differen-
tiation and function (1). However, the UniGene data base
analysis (UniGene cluster Hs.4113) and our multiple tissue
expression array analysis3 indicated that hAHCYL1 is also
expressed in nonhematopoietic tissues, especially at high
levels in neuronal and renal tissues.
Recently, Ando et al. (6) showed that AHCYL1 is identical to
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an inositol 1,4,5-trisphosphate receptor (IP3R)-binding protein
(termed IP3R-binding protein released with inositol 1,4,5-
trisphosphate, or IRBIT). Binding of AHCYL1 to IP3R, an
important regulator of intracellular Ca2 release, is mediated
by its N-terminal domain, and its phosphorylation appears to
be essential for the AHCYL1 binding. Importantly, the
AHCYL1 binding site on IP3R alsomediates the IP3-IP3R inter-
action, suggesting that AHCYL1 regulates IP3 binding to the
IP3R. The consequence of AHCYL1 interacting with the IP3R
remains to be elucidated, but it is of significant interest given
the important regulating role other molecules (and other sig-
naling pathways) have on Ca2 as a result of IP3R activation.
To investigate the function of AHCYL1, we chose the
zebrafish (Danio rerio) as a model organism for molecular
genetic analysis. We describe the cDNA cloning and genomic
organization of the zAHCYL1, compare them with those of
hAHCYL1 and other AHCYL1 homologs, and demonstrate the
effect of suppression and overexpression of AHCYL1 on
zebrafish development.
EXPERIMENTAL PROCEDURES
In Silico Cloning of zAHCYL1—Expressed sequence tags
(ESTs) corresponding to zAHCYL1 were identified in the
dbEST data base from the National Center for Biotechnology
Information (NCBI) by performing a BLASTn search using
hAHCYL1 coding sequence as the query. Nine overlapping
ESTs (GenBankTM accession numbers CA473816, BI473660,
BI885096, CD284541, BI430354, BI884776, BI473380,
CD594351, and BF937243) were compiled using Sequencher
software (GeneCodes, AnnArbor,MI) to form a putative zAH-
CYL1 cDNA sequence. This sequence was used to design prim-
ers for cloning the full-length zAHCYL1 cDNA (described
below). Exon/intron boundaries were determined via a
zebrafish genomic BLAST search available from the Ensembl
Zebrafish Genome Server.
Identification of AHCYL1 in Other Species—AHCYL1
orthologs in other species were identified by tBLASTn
searches using hAHCYL1 protein sequence for enquiry on
the NCBI genomic or EST data bases. Searches were con-
ducted in the following organisms (data base used is shown
in parentheses): Anopheles gambiae (genome), Caenorhab-
ditis elegans (genome), Drosophila melanogaster (genome),
Takifugu rubripes (genome), Gallus gallus (EST), Plasmo-
dium falciparum (genome), Saccharomyces cerevisiae
(genome), Xenopus laevis (EST), and the microbial genome
data base (completed genomes only). To confirm that output
sequences were AHCYL family orthologs and not AHCY
orthologs, the sequences were assessed for (i) N-terminal
domain containing conserved Ser/Thr residues and (ii)
alignment with the hAHCY protein using NCBI pairwise
BLAST indicating less similarity to hAHCY than hAHCYL1.
Phylogenic analysis was performed using the programs
ClustalW for multiple sequence alignment and Protdist for
computing the phylogenic tree and bootstrap values with
100 bootstrap cycles. Both programs are available on the
Australian National Genomic Information Service Bioinfor-
matics service (ANGIS; available on the World Wide Web at
www.angis.org.au). The protein sequences included were
AHCYL1 orthologs fromhuman (GenBankTMaccessionnumber
AF315687), zebrafish (GenBankTM accession number AY611473,
this report), fugu fish (GenBankTM accession number BK005364;
this report), and fruit fly (GenBankTM accession number
NM_139489 and NM_206499); AHCYL2 orthologs from human
(GenBankTM accession number NM_015328) and zebrafish
(GenBankTM accession number NM_201340); and AHCY
orthologs from human (GenBankTM accession number
NM_000687),mouse (GenBankTMaccessionnumberBC086781),
zebrafish (GenBankTMaccessionnumberBC044200), and fruit fly
(GenBankTM accession number NM_078609).
Prediction of Phosphorylation Sites and NAD Binding
Domain—Potential Ser/Thr/Tyr phosphorylation sites in the
AHCYL1 protein sequences were assessed using the program
NetPhos 2.0 (7) on the ExPASyMolecular Biology server (avail-
able on the World Wide Web at au.expasy.org). The AHCY
NAD binding region of the AHCYL1 proteins was defined
using the Conserved Domain Database through NCBI.
RT-PCRCloning of zAHCYL1—Total RNAwas isolated from
adult zebrafish head extracted with Trizol (Invitrogen) and
5-rapid amplification of cDNA ends (RACE) for zAHCYL1
using the FirstChoice RLM RACE kit (Ambion, Austin, TX)
carried out according to the manufacturer’s instructions. First
strand cDNA synthesis was carried out using 10 g of the total
RNA, and the primary PCR was performed using the outer
adaptor primer (5-GCTGATGGCGATGAATGAACACTG-
3) and the gene-specific outer primer MK279 (5-GCT-
GAGCTGTAGCTGTCCGTA-3, nucleotides 508–528 of
zAHCYL1A) using AmpliTaq Gold (Applied Biosystems,
Scoresby, Victoria, Australia). The primary PCR product was
further amplified using the inner adaptor primer (5-CGCG-
GATCCGAACACTGCGTTTGCTGGCTTTGATG-3) and
the gene-specific inner primer MK280 (5-TCCTGTTTGTC-
CTCCTGGTT-3, nucleotides 425–444 of zAHCYL1A) (see
Fig. 1). The PCR was performed on a PTC 200 thermal cycler
(MJ Research,Waltham,MA)with the following reaction cycle:
94 °C for 10 min; 35 cycles of 94 °C for 30 s, 58 °C for 30 s, and
72 °C for 30 s; 72 °C for 10 min.
Cloning of full-length zAHCYL1 coding sequence was
performed using a Thermoscript RT-PCR system (Invitro-
gen). Briefly, 1g of total RNA from adult zebrafish head was
subjected to first strand cDNA synthesis using oligo(dT)20
reverse primer. To obtain full-length zAHCYL1 coding
regions, gene-specific primers nested to the zAHCYL1 5- and
3-untranslated region were synthesized: MK350 (5-CGACA-
GCTTGTTCTCCTTCC-3) and MK352 (5-AAGAGCTCA-
GGCCAGACACA-3), corresponding to exon 1 (nucleotides
58–77) and exon 2 (nucleotides 9–28), respectively, as the for-
ward primers and MK351 (5-AAGCCACACAGACATC-
CTTTTT-3), corresponding to nucleotides 2288–2310, as the
nested reverse primer. PCR products were cloned into
pGEM-T Easy vector (Promega, Annandale, New SouthWales,
Australia) for sequencing.
Identification of Alternatively Spliced hACHYL1—Alterna-
tive N-terminal splicing of hAHCYL1was identified in humans
using the dbEST data base available from NCBI. In order to
identify sequences of authentic splice variants, we searched for
ESTs that (i) contained sequence that overlapped substantially
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with known hAHCYL1 cDNA and (ii) could be mapped to the
chromosome band 1p12 for the hAHCYL1 gene (1).
Quantitative RT-PCR—Total RNA purified from zebrafish
embryos at different stages of development (50–100 embryos/
stage) using Trizol (Invitrogen) was treated with DNase I
(Invitrogen) to remove contaminating genomic DNA and sub-
jected to cDNA synthesis with random hexamers using Expand
reverse transcriptase (Roche Applied Science). For quantitative
RT-PCR analysis, the cDNA was combined with gene-specific
forward and reverse primers for zAHCYL1A, zAHCYL1B,
zAHCYL2, and zAHCY and a SYBR green master mix (Quan-
tiTect SYBR PCR kit, Qiagen, Clifton Hill, Victoria, Australia)
and subjected to real time PCR using a Rotorgene 3000 thermal
cycler (Corbett Research, Mortlake, New SouthWales, Austra-
lia). Zebrafish glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used for normalization of cDNA input. The prim-
ers were zAHCYL1A, MK279, and MK391 (5-ACAGCGAG-
GTGAACATGAAC-3); zAHCYL1B, MK279, and MK352;
zAHCYL2, MK388 (5-TCTTGGTGGGACGTTTGTTG-3),
and MK390 (5-ACCGAGCCCCATGAAGAT-3); and
zebrafish GAPDH, MK293 (5-CCCAATGTCTCTGTTGT-
GGA-3), and MK294 (5-CGTGTAGAGCAATACCA-
GCA-3). The standard curves were generated using serially
diluted gene-specific amplicons. The thermal cycling condi-
tions were as follows: initial denaturation at 95 °C for 15min,
45 cycles of 95 °C for 15 s, 58 °C for 15 s and 72 °C for 30 s,
followed by melting temperature analysis (72–99 °C with
1 °C increments). Data analysis was performed using Rotor-
gene 5.0 software (Corbett Research). The amplification was
specific as judged by melting temperature analysis, agarose
gel analysis, and DNA sequencing of the amplicons. The
experiments were performed in duplicate and repeated at
least twice.
Production of Rabbit Anti-AHCYL1 Peptide Antibody—Rab-
bit polyclonal peptide antisera against the AHCYL1C-terminal
peptide were produced by immunizing New Zealand White
rabbits with diphtheria toxoid-conjugated synthetic peptide
CGPFKPNYYRY (Mimotopes, Clayton, Victoria, Australia)
using a conventional schedule with Freund adjuvant at theHer-
ston Medical Research Center (Herston, Queensland, Austra-
lia). The titer of the antibody against the peptide was assessed
by enzyme-linked immunosorbent assay using an enzyme-
linked immunosorbent assay plate (Maxsorb; Nalge Nunc,
Rochester, NY) coated with streptavidin (Sigma) and biotin-
ylated peptides for AHCYL1 (biotin-SGSGCGPFKPNYYRY).
The antibody was purified with a series of affinity column chro-
matography using a HiTrap protein A and a HiTrap streptavi-
din (Amersham Biosciences) conjugated with the biotinylated
C-terminal AHCYL1 peptide. The antibody reacted with both
AHCYL1 and AHCY in Western blot analysis.
Zebrafish Maintenance and Collection of Embryos—Zebrafish
were maintained under standard conditions as described (8) and
used under the protocols approved by University of Queens-
land Animal Ethics Committee. Embryos were obtained from
natural spawning of adult fish on a 14-h light/10-h dark cycle
and were raised at 28 °C. Stages were determined by both hours
postfertilization (hpf) and morphologic features (9). Photo-
graphs were taken on a SPOT digital camera setup (Diagnostic
Instruments Inc, Sterling Heights, MI) using a Leica S240 dis-
secting microscope equipped with an epifluorescent system.
Morpholino Antisense Oligonucleotides against AHCYL1
for Microinjection—The morpholino antisense oligonucleo-
tides MO1A (5-TGGCATCCTCGCCACAGTCTGTCAT-3)
and MO1B (5-CATGGTTCATGTTCCCTGTGTGTGT-3)
against zAHCYL1A and zAHCYL2 (see Fig. 1), and a standard
control morpholino antisense oligonucleotide (5-CCTCTTA-
CCTCAGTTACAATTTATA-3) were obtained from Gene
Tools (Philomath, OR). Zebrafish embryos at the 1–2-cell stage
weremicroinjected (0.5 nl/embryo) with themorpholino oligo-
nucleotides (1, 0.5, or 0.2 mM) mixed with synthetic capped
enhanced green fluorescent protein (EGFP), E1/EGFP, or
E2/EGFP mRNA (0.125 mg/ml, described below).
Production of pCS2-hAHCYL1, pCS2-hAHCY, and pCS2-
zAHCYL1 mRNA Synthesis Vectors—The cDNAs of human
and zebrafishAHCYL1 and humanAHCY cDNA, including 5-
and 3-untranslated regions were cloned into the pCS2
expression vector (10). Briefly, hAHCYL1A sequence was
excised from the clone 211(1)B (1) using XbaI and SacI, and
ligated into the corresponding sites available in pCS2 to gen-
erate pCS2-hAHCYL1A. The human AHCY cDNAwas ampli-
fied using RT-PCR from pooled human cDNA (from mono-
cyte-derived dendritic cells and cell lines (i.e. L428 and HL60))
using primers MK276 (5-CGGCCCAGTTCCTGTTCC-3)
and MK277 (5-GCTCATGGTTCCCTGTGG-3) using a Taq
polymerase (Roche Applied Science). The PCR product was
cloned into pGEM-T Easy vector for sequence confirmation.
The insert was excised with NotI and SpeI, NotI site-blunted,
and subcloned into pCS2 with blunted BamHI and SpeI
sites. The zAHCYL1A sequence was derived from the
pGEM-T Easy vector clone (described above) and cloned
into pCS2 using a strategy similar to that described for the
human AHCY clone. All plasmids were linearized with NotI
for in vitro mRNA synthesis.
Production of pCS2-E1/EGFP and pCS2-E2/EGFP mRNA Syn-
thesis Vectors—zAHCYL1 cDNAs encoded by the exon 1 and
exon 2 were PCR-amplified with Pfu polymerase (Stratagene, La
Jolla, CA) using sets of primers MK350/MK380 (5-GCACCAT-
GGCCTCCTGGTTGGCAAACTGAA-3, NcoI site underlined)
for exon 1 andMK352/MK382 (5-GCATCATGACCTCCTGG-
TTGGCAAACTGAA-3, RcaI siteunderlined) for exon2, respec-
tively (see Fig. 1). The PCR products were cloned into
pCS2EGFP digested with SmaI/NcoI or SmaI/RsaI so that the
cloned exons were in frame with EGFP.
Capped mRNA Synthesis and Microinjection—Capped
mRNAwas synthesized using a SP6 mMessage mMachine kit
(Ambion, Austin, TX). EGFP (an injection control) mRNA
was prepared as described previously (10). RNA was purified
by phenol/chloroform extraction followed by ethanol pre-
cipitation and resuspended to a concentration at 1.5 mg/ml,
and integrity was checked by formaldehyde denaturing gel
electrophoresis. Zebrafish embryos at the 1–2-cell stage
were microinjected (0.5 nl/embryo) with the synthesized
mRNA (1 mg/ml) mixed with EGFP mRNA (0.125 mg/ml).
Only EGFP-positive embryos were examined at 12–28 hpf
and scored according to the severity of their morphological
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defects. Embryos injected with EGFP mRNA at 1.2 mg/ml
were used as injection controls.
Depletion of Intracellular Calcium Stores—Thapsigargin
treatment of embryos was performed according to Westfall
et al. (11). Briefly, a 5 mM thapsigargin (Sigma) stock solution
wasmade inMe2SO. 32–64-cell stage embryos were incubated
with 5M thapsigargin diluted in eggmedium (8). Me2SO-only
incubations were used as a negative control. After a 1-h incu-
bation, embryos were washed extensively in egg medium and
incubated at 28 °C in embryo media until required.
Western Blot Analysis—Zebrafish
embryos (1–2-cell stage) were
injected with synthetic hAHCYL1,
zAHCYL1, or hAHCY mRNA (1.5
mg/ml) in combination with EGFP
mRNA and incubated for 6 h. EGFP-
positive embryos were harvested and
lysed with 1% Triton X-100, 50 mM
Tris-HCl, pH 7.4, and a protease
inhibitor mixture (Complete; Roche
Applied Science), 1 mM phenylmeth-
ylsulfonyl fluoride (Sigma), and 5mM
EDTA, and the lysate was cleared by
centrifugation at 20,000  g for 10
min at 4 °C. The protein concentra-
tion was determined by a BCA pro-
tein assay (Pierce)usingbovine serum
albumin as standard. The lysate was
aliquoted and stored at 70 °C until
use. Forpositive controls,COS-7 cells
in two 100-mm dishes were trans-
fected with pCS2-hAHCYL1 or
pCS2-hAHCY (5 g/dish) using
Fugene 6 (Roche Applied Science)
according to the manufacturer’s pro-
tocol and incubated for 48h.Thecells
were lysed with the lysis buffer, and
protein concentration was deter-
mined as above.
The lysate from the zebrafish
embryos (250 g) and COS-7 cell
transfectants (20 g) was fraction-
ated with a 4–12% gradient SDS-
polyacrylamide gel (NuPAGE;
Invitrogen) in reducing conditions
and transferred onto a polyvinyli-
dene difluoride membrane (PVDF-
Plus, Osmonics, Westborough, MA).
The membrane was blocked with 5%
nonfat skim milk, 0.1% Tween 20
(Sigma) in phosphate-buffered saline
and incubated sequentially with the rabbit anti-AHCYL1 pep-
tide antibody (5g/ml) andhorseradish peroxidase-conjugated
goat anti-rabbit IgG (1:5000 dilution; Chemicon, Boronia, Vic-
toria, Australia) and the signals detected with enhanced chemi-
luminescence (Pierce).
RESULTS
Cloning of zAHCYL1 and Its Genomic Organization—The
AHCYL1 gene is highly conserved among species (e.g. 100% protein
FIGURE 1.Molecular cloning of zAHCYL1 cDNAs. A, 5-RACE cloning of alternatively spliced zAHCYL1 variant cDNAs. The cloning strategy is depicted in the
left panel. Zebrafish total RNAwas subjected to 5-RACE, and the product was resolved in a 2% agarose gel and visualizedwith ethidiumbromide (right panel).
DNAstandards are indicatedon the right.B, the complete cDNAandaminoacid sequenceof zAHCYL1Aencodedby17exons, includingexon1andexons3–18.
C, the partial cDNA and amino acid sequence of zAHCYL1B encoded by exon 2 and the beginning of exon 3. The solid arrows indicate the position of
gene-specific primers used for 5-RACE and theproductionof pCS2-E1/EGFPandpCS2-E2/EGFP. Thedashedarrows indicate the target sites for themorpholino
antisense oligonucleotides (MO1A and MO1B) against zAHCYL1A and -B, respectively. Exon/intron junctions are indicated by vertical arrows and numbered
according to exon number. The kinked arrows indicate start sites identified by 5-RACE.
FIGURE2.Genomicorganizationandalternative splicingofAHCYL1 inzebrafish (AandB) andhumans (C
and D). A, schematic representation of the zAHCYL1 gene and the alternative 5 exon splicing. The gene
consists of 18 exons (E1–E18, indicated by boxes). B, deduced protein structure of zAHCYL1 variants. The two
variants, zAHCYL1A and -B, differ at the N terminus of the protein due to the alternative use of either exon 1 or
exon2. Theboxes indicate exons, and thenumbers correspond to the exonnumber. TheN-terminal hydrophilic
domain is shaded gray. C, schematic representation of hAHCYL1 genome and the alternative exon usage to
producehAHCYL1mRNA splicing variants (AHCY1A–AHCY1). Thegene consists of 20 exons (E1–E20, indicated
by boxes).D, deduced protein structure of hAHCYL1 variants. Although the alternative splicing produces three
variant mRNAs (AHCYL1A, B, and C), only two variant proteins are produced, because both exon 2/3 and exon
4 encode only 5-untranslated sequence, and the translation start site appears to bewithin the common exon
5. aa, amino acids.
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identity between human andmouse) (1). To clone the zAHCYL1,
we conducted a BLAST search using the coding sequence for
hAHCYL1 cDNA (GenBankTM accession number AF315687) to
search theNCBI zebrafishESTdata base.TheESTsobtainedwere
aligned to establish a consensus zAHCYL1 cDNA sequence,
which was confirmed by RT-PCR and DNA sequencing.
To determine the transcriptional start site on zAHCYL1
mRNA, we performed 5-RACE analysis using primers
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nested in the 5-zAHCYL1 cDNA in the adult zebrafish
head-derived cDNA library. This resulted in two PCR prod-
ucts (450 and 250 bp) (Fig. 1A). Sequencing analysis
revealed that these two products corresponded to two zAH-
CYL1 mRNA variants with mutually exclusive transcription
start sites termed zAHCYL1A and zAHCYL1B (Fig. 1, B and
C). The zAHCYL1A sequence corresponded to the zAH-
CYL1 sequence obtained by EST data base search and con-
firmed using RT-PCR (Fig. 1B). This was identified as the
ortholog of hAHCYL1 (described below). The zAHCYL1B
sequence contained a previously uncharacterized 46-bp
alternative 5-untranslated region plus an alternative coding
sequence for the N-terminal 9 amino acids, assuming that
the first ATG in the sequence is the initiation codon (Fig.
1C). These results suggested that at least two alternatively
spliced variants of zAHCYL1 were present.
To determine the full genomic structure of zAHCYL1A and
-B, we performed a BLAST search of the Ensembl zebrafish
genomic sequence data base. One BAC clone (GenBankTM
accession number AL773601) contained all of the cDNA
sequences, and we determined the intron-exon boundaries
using the “GT-AG” splice site consensus by comparing the
genomic sequence with these cDNA sequences. We found the
zAHCYL1 gene consisted of 18 exons spanning 39 kb (Fig. 2A).
The zAHCYL1A transcript was encoded by 17 exons (with
exon 2 spliced out), and the last 15 exons encoded the AHCY-
like domain, similar to hAHCYL1.The zAHCYL1B transcript is
also encoded by 17 exons but uses exon 2, located 9.2 kb down-
stream of exon 1, as an alternative first exon.
The putative zAHCYL1A protein (encoded by exons 1 and
3–18) consists of 554 amino acids with an N-terminal hydro-
philic domain (130 amino acids; exons 1, 3, and 4) and an
AHCY-like domain (424 amino acids; exons 4–18) (Fig. 2B).
The putative initiation codon was identified by comparing the
zAHCYL1 protein to that of T. rubripes AHCYL1 protein
(assigned GenBankTM accession number BK005364). The
zAHCYL1B protein (exons 2 and 3–18) consists of 500 amino
acids with the N-terminal hydrophilic domain being only 76
amino acids (exons 2–4) (Fig. 2B). Its initiation codonwas iden-
tified as the first methionine in exon 2.
Next we investigated possible alternative usage of 5 exons in
hAHCYL1 (now termed hAHCYL1A). By carrying out an
extensive analysis of human EST sequences, we identified two
ESTs encoding previously uncharacterized, alternatively
spliced hAHCYL1 mRNAs termed hAHCYL1B and -C (Fig.
2C). hAHCYL1B was represented by two ESTs (GenBankTM
accession numbers T19009 and BI460083) encoded by two sep-
arate exons (i.e. exons 2 and 3) joined to exon 5 (Fig. 2C).
hAHCYL1C was represented by three ESTs (GenBankTM
accession numbers AU279527, AL036027, and BF930049),
which contained another alternative exon 4 (Fig. 2C). These
three newly identified exon sequences (exons 2–4) could be
joined by proper intron/exon junctions to exon 5. However, the
only putative initiation codon appeared in exon 5, suggesting
that these exons encoded alternative 5-untranslated regions
for truncated hAHCYL1 proteins, which lacked nearly half of
the N-terminal hydrophilic domain (Fig. 2D).
AHCYL1 Protein Is Evolutionarily Conserved among Species—
We used phylogenic analysis to assess the evolutional relation-
ships between the orthologs of AHCYL1, AHCY, and the other
member of the AHCY-like protein family in zebrafish, zAH-
CYL2 (GenBankTM accession number AAH5951), a possible
ortholog of hAHCYL2 (GenBankTM accession number
BC024325) (3). The AHCYL1 genes were distinguished from
AHCY genes, suggesting that AHCYL1 diverged early from
AHCY and evolved separately (Fig. 3A). Furthermore, both
zebrafish and human AHCYL2 were more closely related to
AHCYL1 than AHCY. Fruit fly AHCY-like proteins (CG9977
and AHCY89E), which also have an N-terminal hydrophilic
domain and an AHCY-like domain, clustered with AHCYL1
and AHCYL2.
The amino acid comparison between the human and
zebrafish AHCYL1A proteins show 93% identity and 97% sim-
ilarity, across the region encoded by human exons 5–20 and the
zebrafish exons 3–18 (Fig. 3B). Comparison with additional
AHCYL1A orthologs (frommouse, fugu fish, and fruit fly) con-
firmed that theAHCY-like domains, including theNADbind-
ing domains (161 amino acids) were highly conserved in the
AHCYL1 orthologs (Fig. 3B). In addition to highly conserved
Cys, 27 predicted Ser/Thr/Tyr phosphorylation sites were con-
served among all vertebrates analyzed, 16 of which were clus-
tered in the N-terminal hydrophilic domain (Fig. 3B). The
majority of these Ser/Thr/Thr residues were also conserved in
the fruit fly AHCYL protein. The protein sequences encoded by
exon 1 are highly diverse between species, with zAHCYL1 pro-
teins being 24 amino acids longer than hAHCYL1 at the N
terminus. These data suggest that Ser/Thr/Tyr phosphoryla-
tion and NAD binding are likely to play an important role in
AHCYL1 function.
zAHCYL1A and -B and zAHCYL2 mRNA Are Regulated
during Embryogenesis—We investigated the expression of
zAHCYL1A and -B, zAHCYL2 and zAHCY mRNA in devel-
oping zebrafish embryos by real time RT-PCR (Fig. 4).
Zebrafish GAPDH was used to normalize the cDNA input.
zAHCYL1Awas first apparent at the shield stage of embryos,
and its expression was steadily increased until the 25-somite
stage. At 25 hpf, its expression decreased markedly to half
that of the 25-somite stage. zAHCYL1B mRNA expression
FIGURE 3. The AHCYL1 genes are evolutionarily conserved among species. A, phylogenic analysis of AHCYL homologs. Protein sequences from AHCY/
AHCY-like domains of AHCY, AHCYL1, and AHCYL2 orthologs were subjected to phylogenic analysis with 100 bootstrapping cycles. The numbers indicate the
bootstrap values generated using the neighbor joining method. Drosophila AHCY (dAHCY) was chosen as the outgroup. The tree is unrooted. Homologs
included are as follows: human and mouse AHCYL1A (identical protein sequences), zAHCYL1A, fugu fish AHCYL1 (fAHCYL1), hAHCYL2, zAHCYL2, fruit fly
AHCY-like proteins (dCG9977 and dAHCY89E), hAHCY, mouse AHCY (mAHCY), and zebrafish AHCY (zAHCY). B, amino acid comparison between five AHCYL1A
orthologs from human, mouse, zebrafish, fugu fish, and fruit fly (dCG9977). AHCY-like domains are boxed. Amino acids identical to hAHCYL1 are indicated by
dots. Conservatively replaced amino acids are shaded by gray boxes. Gaps are shown as dashes. The NAD bindingmotif is underlined. The circles and asterisks
indicate conserved Ser/Thr/Tyr and Cys in vertebrate AHCYL1A orthologs, respectively. The filled circles indicate potential Ser/Thr/Tyr phosphorylation sites.
The vertical arrows indicate the exon-intron junctions of zAHCYL1A (see Fig. 1).
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increased from very low levels at the shield stage, peaking at
the bud stage. Its expression then decreased to very low lev-
els by the 15-somite stage and remained low until 25 hpf.
zAHCYL1B mRNA expression levels were much lower over-
all than those of zAHCYL1A (20%). In contrast to the reg-
ulation of zAHCYL1A and -B mRNA during development,
zAHCY mRNA was present before cell division and
expressed at much higher levels in developing embryos. Its
increase throughout development
was consistent with the proposed
role of zAHCY as a housekeeping
gene. Finally, zAHCYL2 mRNA was
also present before cell division at
high levels and remained so until the
15-somite stage before decreasing
markedly at the 25 hpf stage to levels
similar to zAHCYL1A. These data
indicated that zAHCYL1A and
-1B expression underwent signifi-
cant regulation and that both were
likely to be important in zebrafish
embryogenesis.
Suppression of zAHCYL1A and -B
by the Morpholino Antisense Oli-
gonucleotides Induces Ventralized
Morphologies in Zebrafish Em-
bryos—To investigate the function
of zAHCYL1A and B in developing
embryos, we used morpholino antisense oligonucleotides
against zAHCYL1A and -B. First, we examined the specific-
ities of the morpholino oligonucleotides by coinjecting the
synthetic fusion mRNAs containing zAHCYL1 exon 1 (E1/
EGFP mRNA, zAHCYL1A-specific) or exon 2 (E2/EGFP
mRNA, zAHCYL1B-specific) fused in frame with EGFP and
the gene-specific morpholinos (MO1A and MO1B for
zAHCYL1A and -B, respectively) into 1–2-cell stage
FIGURE 4. The expression of zAHCYL1A and -B and zAHCYL2mRNA is regulated during embryogenesis. Total RNA purified from various developmental
stages of zebrafish embryos were subjected to real time RT-PCR analysis for quantitation of zAHCYL1A, zAHCYL1B, zAHCYL2, and zAHCY mRNA. Zebrafish
GAPDH was used to normalize the cDNA input.
FIGURE 5. The morpholino oligonucleotides (MO1A and MO1B) against zAHCYL1A and -B specifically
reduce the target gene expression. The fusionmRNA encoding EGFP and the zAHCYL1 exon 1 (E1, contain-
ing theMO1A target) (A and B) or the exon2 (E2, containing theMO1B target) (C andD) was coinjectedwith the
MO1A or MO1B, and expression of EGFP was analyzed by epifluorescence microscopy. The insets show the
same field viewed by light microscopy.
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zebrafish embryos. The embryos were incubated overnight,
and the gene-specific morpholino effects were assessed by
the EGFP expression levels in the embryos. As shown in Fig.
5, MO1A suppressed the translation of the E1/EGFP mRNA
completely, but not that of the E2/EGFP mRNA. Conversely,
MO1B abolished E2/EGFP mRNA translation, but not that
of E1/EGFP mRNA translation, indicating that MO1A and
MO1B could inhibit specifically zAHCYL1A and -B transla-
tion, respectively.
When MO1A at 1 mM were
injected into 1–2-cell stage zebrafish
embryos and incubated overnight,
the resultant embryos were often
necrotic, and the surviving embryos
showed severe and gross body axis
deformities (Fig. 6A, Table 1). Injec-
tion of the MO1A at 0.5 mM pro-
duced a ventralized morphology,
with abnormally developed and
necrotic brain structures and
expanded ventral tail fin tissue (Fig.
6B). Injection of further diluted
MO1A had no morphological effect
(data not shown). Injection of 1 mM
or 0.5 mMMO1B resulted in similar
numbers of severely deformed
embryos (Fig. 6A). Injection of
MO1B diluted further to 0.2 mM
produced a ventralized morphology
similar to that observed with the 0.5
mM MO1A injections (Fig. 6B). The
apparent potency of MO1B com-
pared with MO1A may be because
zAHCYL1B mRNA was less abun-
dant (see Fig. 4). Embryos injected
with a control morpholino at 1 mM
showed no abnormalmorphologies.
The similar morphologies, which
were observed after the MO1A and
MO1B injections, suggested that
zAHCYL1A and -B have similar
functions.
Microinjected Synthetic hAHCYL1A
and hAHCY mRNA Are Translated
into Cognate Proteins in Zebrafish
Embryos—The zAHCYL1 antisense
morpholino studies showed that
AHCYL1 might play a role in dor-
salization, and the mRNA expres-
sion data suggested that its function
was different from that of AHCY
(see Fig. 4). Therefore, we hypothe-
sized that AHCYL1 overexpression
in zebrafish embryos would induce
dorsalized phenotypes and that this
outcome would differ from that
resulting from AHCY overexpres-
sion. To test this, we first investi-
gated the translation of the injected synthetic mRNAs into the
cognate proteins. The capped mRNA encoding hAHCYL1A
and hAHCY, synthesized using pCS2-hAHCYL1A and pCS2-
hAHCY as templates, were injected into 1–2-cell stage
zebrafish embryos. The embryos were incubated for 6 h, lysed
in a lysis buffer, and subjected to Western blot analysis using
the anti-hAHCYL1 peptide antibody, which binds to both
AHCYL1 and hAHCY. As shown in Fig. 7, the embryos injected
with the hAHCYL1A mRNA expressed a substantial 58.7-kDa
FIGURE 6. zAHCYL1 gene knockdown by MO1A or MO1B injection induces ventralization in zebrafish
embryos. A, zebrafish embryos were injected with 1 mM MO1A or -1B and observed at 24 hpf. B, zebrafish
embryos were injected with 0.5 mM MO1A or 0.2 mM MO1B and observed at 24 hpf. The standard control MO
did not induce any gross phenotypes. The arrowheads and arrows indicate necrotic heads and expanded
ventral tail fins, respectively.Magnification forwhole embryos is25;magnification forpartial embryos is50.
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protein band corresponding to the hAHCYL1 protein, com-
pared with the embryos injected with the hAHCYmRNA or to
uninjected control embryos. The hAHCYL1 protein translated
in zebrafish embryos was the same size as the AHCYL1 protein
expressed in the COS-7 cells transiently transfected with the
pCS2-hAHCYL1. The hAHCY mRNA was also translated into
the protein in the zebrafish embryos as well; however, the
expression levels did not change markedly because of high lev-
els of endogenous zAHCY.
Microinjection of AHCYL1AmRNA Induces DorsalizedMor-
phologies in Zebrafish Embryos—The high levels of conserva-
tion of AHCYL1A proteins between species suggested that
these proteins may have similar cross-species function. We
injected the synthetic hAHCYL1AmRNA and hAHCY into the
1–2-cell stage zebrafish embryos and examined them after
overnight incubation (Figs. 8 and 9). Those embryos injected
with hAHCYL1A mRNA displayed marked morphological
defects, whichwere categorized based on the severity according
to Mullins et al. (12) (Table 2). During the segmentation stage,
the moderately affected embryos (C1–C3 grade) were charac-
terized by a shortened protruding tail bud. The tail bud did not
extend around the yolk as in wild type but rather protruded
from the yolk sac and was slightly enlarged (Fig. 8E). The heads
of these embryos were also slightly enlarged, often exhibiting a
prominent square shape. These embryos also exhibited an
increase in the distance between the head and tail bud, sug-
gesting inhibition of convergent extension movement (Fig.
8E). At the pharyngula stage, the majority of hAHCYL1A
mRNA-injected embryos displayed prominent tail shortening/
kinking defects (Fig. 8C). Severely affected embryos (C4–C5
grade) had more pronounced changes characterized by a com-
plete loss of posterior structure and severely reduced anterior
structure (Fig. 8C; see below)with a duplicated axis also evident
in some embryos (Fig. 8C, higher magnification). These hAH-
CYL1 mRNA-induced morphological defects were consistent
with the features associated with dorsalization (12). Only 1% of
embryos injected with EGFP mRNA showed abnormalities,
indicating that the morphological defects in hAHCYL1
mRNA-injected embryos were specific to hAHCYL1A overex-
pression. In contrast, the majority of hAHCY mRNA-injected
embryos displayed normal conversion extension movement
comparablewith thewild type at segmentation stage, indicating
that gastrulation movements during segmentation were not
disrupted (Fig. 8, B and G). These data suggested that
AHCYL1A differed from AHCY in function.
It was possible that differences in protein structure (mostly
localized at the N-terminal hydrophilic domain) between
human and zebrafish AHCYL1A mediated species-specific
function of AHCYL1A. Thus, we examined the effect of
zAHCYL1A overexpression during embryogenesis (Fig. 8 and
Table 2). Embryos injected with zAHCYL1A mRNA displayed
morphological defects similar to those with hAHCYL1 expres-
sion. At the segmentation period, the moderately affected
embryos (C1–C3) displayed a protruding tail bud similar to that
seen in hAHCYL1 mRNA-injected embryos (Fig. 8F). Unlike
hAHCYL1AmRNA injected embryos, the head shape appeared
to be normal in zHCYL1 mRNA-injected embryos. Interest-
ingly, the transient Kupffer’s vesicle appears enlarged in
zAHCYL1AmRNA-injected embryos. At the pharyngula stage,
embryos displayed a shortened and kinked tail structure similar
to that observed with hAHCYL1mRNA-injected embryos (Fig.
8H). Those embryos with a moderate dorsalized morphologies
(C1–C3) showed reduced circulation (data not shown), thick-
ened/split notochord, and loss of ventral tail tissue (Fig. 9).
More severely affected embryos exhibited severe dorsalization
(C4–C5 grade) characterized by complete loss of posterior
structure as seen in hAHCYL1AmRNA-injected embryos (Fig.
8H), suggesting that function of AHCYL1A orthologs was
largely conserved among species.
Dorsalized morphologies of zebrafish embryos were evident
when the phosphatidylinositol cycle was inhibited (11). The
phosphatidylinositol cycle is responsible for generating IP3R-
dependent intracellular Ca2 release through the action of a
secondmessenger, IP3 (13). BecauseAHCYL1 binds to the IP3R
FIGURE 7. Translation of injected synthetic mRNA in zebrafish embryos.
Zebrafish embryos (1–2-cell stage) were injected with synthetic hAHCYL1
and hAHCY mRNA and incubated for 6 h. The embryos were lysed and sub-
jected to Western blot analysis for the cognate proteins. Cell lysate from
COS-7 cells transfected with hAHCYL1 or hAHCY expression vector was used
as positive control. The single and double asterisks indicate the position of
endogenous zAHCYL1 and zAHCY, respectively. Molecular mass standards
are indicated on the right.
TABLE 1
Summary of zebrafish morphologies after mRNA injection
of morpholino oligonucleotides against zAHCYL1A and -B
Zebrafish embryos (at the 1–2-cell stage) were microinjected with morpholino oli-
gonucleotides (MO) as indicated. Embryos were observed at 24 hpf for morpholog-
ical defects.
Treatment n Necrotized Abnormal Normal
1 mM MO1A 110 5 (4.5%) 102 (92.7%) 3 (2.7%)
0.5 mM MO1A 30 0 (0%) 24 (80%) 6 (20%)
0.2 mM MO1A 49 0 (0%) 2 (4.1%) 47 (95.9%)
1 mM MO1B 70 56 (80%) 11 (15.7%) 3 (4.3%)
0.2 mM MO1B 52 11 (21.2%) 41 (78.8%) 0 (0%)
Standard
control MO
73 0 (0%) 4 (4.5%) 69 (94.5%)
Uninjected 111 0 (0%) 2 (1.8%) 109 (98.2%)
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(6), we wondered whether overexpression of AHCYL1 in
zebrafish embryo caused perturbation of intracellular Ca2
release. Therefore, we cultured zebrafish embryos in the pres-
ence of thapsigargin and compared their morphology with
those obtained after overexpression of zAHCYL1A (Figs. 8 and
9). Thapsigargin inhibits the Ca2ATPase-mediated return of
Ca2 into the endoplasmic reticulum, causing depletion of
intracellular Ca2 stores and inhibition of Ca2 signaling path-
ways (14). Consistent with the report byWestfall et al. (11), we
found that thapsigargin caused the majority of zebrafish
embryos to display severe dorsalization (C4–C5 grade; Fig. 8I
and Table 2), similar to AHCYL1A mRNA-injected embryos.
Upon close inspection of moderately affected embryos (C1–C3
grade), both thapsigargin-treated and AHCYL1A mRNA-
injected embryos displayed a reduced circulation (data not
shown), loss of ventral tail fin tissue (Fig. 9, top panels), and
thickened/twisted notochord (Fig. 9, bottom panels), all fea-
tures associated with dorsalization. Control embryos treated
with 0.1% Me2SO (solvent control) had no morphological
defects (data not shown). These data suggested that overex-
pression of zAHCYL1A interfered with the signaling pathways
involved in phosphatidylinositol/Ca2 signaling, inducing dor-
salized phenotypes in zebrafish embryos.
DISCUSSION
AHCYL1 was presumed to be a protein with AHCY-like
enzymatic activity because of its high protein identity with
AHCY. We now provide evidence that AHCYL1 differs from
AHCY both in its evolution and function.
AHCY is a functionally conserved and ubiquitously
expressed enzyme that catalyzes the reversible hydrolysis of
S-adenosyl-L-homocysteine, the by-product of the S-adenosyl-
L-homomethionine-dependent transmethylation reaction, into
adenosine and homocysteine using NAD as a cofactor (2).
AHCY is indispensable for the methylation reaction, because
the accumulation of S-adenosylhomocysteine inhibits the
methyltransferase activity. Deletion of the AHCY gene in mice
results in early embryonic lethality (15), and in humans AHCY
deficiency leads to severe growth restriction anddevelopmental
abnormalities (16). AHCY was thought to be a cytoplasmic
enzyme, but it has been shown recently that AHCY translocates
from the cytoplasm to the nucleus during cell culture as well as
FIGURE 8. Ectopic expression of AHCYL1 in zebrafish embryos induces dorsalization of the embryos similar to inositol phospholipid signaling
pathway inhibition with thapsigargin (low power). A, wild-type (WT) embryos injected with EGFP mRNA (24 hpf). B, embryos injected with human
AHCY mRNA (24 hpf). C, embryos injected with hAHCYL1 mRNA exhibited a moderate and severe phenotype (24 hpf). Note that hAHCYL1
mRNA-injected embryos show different morphological defects from human AHCY mRNA-injected embryos at 24 hpf. The right panel shows higher
magnification of the severely affected embryo with axis duplication (each axis indicated by asterisks). D, wild-type embryos injected with EGFP mRNA;
E, embryos injected with hAHCYL1 mRNA; F, embryos injected with zAHCYL1 mRNA (14-somite stage). The double-headed arrows indicate the distance
between the head and tail bud. The arrowhead indicates the tail bud, protruding in human and zebrafish AHCYL1-injected embryos. Note that embryos
injected with human AHCY mRNA and wild-type embryos do not show any increase in distance between the head and tail bud (12-somite stage). H,
embryos injected with zAHCYL1 mRNA exhibited the moderate and severe phenotype at 24 hpf. I, embryos treated with thapsigargin at 24 hpf.
Magnification is 25.
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during X. laevis embryogenesis (17). Moreover, it complexes
with mRNA(guanine-7-)methyltransferase and RNA polymer-
ase II (18), further suggesting that AHCY contributes to funda-
mental cellular functions as well as embryonic development.
Protein sequences for AHCY orthologs have been identi-
fied from more than 30 different species, including bacteria,
plants, and vertebrates (2). Our analysis of various prokary-
otic and eukaryotic genomes revealed that the AHCY-like
protein family members (AHCYL1 and AHCYL2) (1, 3) are
only present in segmented multicellular organisms (i.e. ver-
tebrates and insects but not nematode, yeast, malaria, and
prokaryotes), whereas AHCY orthologs are present in all
organisms examined (Table 3). Taken together with the phy-
logenic analysis (Fig. 3), we concluded that AHCYL1 and
AHCYL2 form an evolutionarily distinct family of molecules,
which are likely to have evolved a novel function required in
higher organisms. This fits with the finding that AHCYL1 lacks
important residues found in AHCY that are necessary for
AHCY enzymatic function (1).
Recently, an IP3R-binding protein isolated from a rat brain
extract using an IP3R fusion protein affinity column was iden-
tified as AHCYL1 (6). AHCYL1 binding to IP3R was mediated
by the N-terminal hydrophilic domain and abolished by alkali
phosphatase treatment, suggesting that phosphorylation of
AHCYL1 is essential for the binding. Because many putative
Ser/Thr/Tyr phosphorylation sites in AHCYL1 N-terminal
hydrophilic domain are conserved among species (Fig. 3), it is
likely that the phosphorylation of this domain is important for
AHCYL1 binding to IP3R. Although the functional conse-
quence of AHCYL1 binding to IP3R has yet to be determined, it
may modulate Ca2 release by IP3R. The hydrolysis of phos-
phatidylinositol 4,5-bisphosphate in response to cell surface
receptor activation results in the production of IP3, which in
turn binds to IP3R to release Ca2 stored in the endoplasmic
reticulum. The resulting Ca2 release regulates the activation
of numerous downstream targets important for many cellular
and developmental processes in all higher organisms, including
fruit fly, zebrafish, and mouse (13, 19–21). For example, the
increase of AHCYL1 mRNA that we observed in human DC is
entirely consistentwithCa2 signaling-mediated control ofDC
function (22–25).
Kume et al. (26) produced a series of monoclonal antibodies
againstXenopus IP3R and showed that injection of thesemono-
clonal antibodies into the ventral blastomeres of 4-cell stage
Xenopus embryos converted ventral
mesoderm to dorsal mesoderm,
resulting in dorsalization of the
embryos. Interestingly, no dorsal-
ization was observed when these
monoclonal antibodies were
injected dorsally (26). Westfall et al.
(11) further showed that injection of
one of these monoclonal antibodies
(clone 1G9) into zebrafish embryos
induced dorsalization. Further-
more, depletion of intracellular
Ca2 by thapsigargin induced dor-
salized zebrafish embryos (11).
These results strongly suggest that
theCa2 signalingmediated by IP3R
is important for the normal devel-
opment of ventral but not dorsal
structures in developing embryos,
and perturbation of ventral IP3R
function induces dorsalization of
embryos. We showed that morpho-
lino suppression of zAHCYL1
induced ventralization of zebrafish
embryos, and conversely AHCYL1
overexpression by mRNA injection
FIGURE9.Dorsalizationof zebrafishembryosby zAHCYL1mRNA injection is similar to inositol phospho-
lipid signaling pathway inhibitionwith thapsigargin (magnification50). Ventral tails (upper panels) and
notochords (lower panels) of wild-type (WT) embryos (left panels), zAHCYL1 mRNA-injected embryos (center
panels), and thapsigargin-treated embryos (right panels) are shown. Note that both AHCYL1 mRNA-injected
and thapsigargin-treated embryos show the loss of ventral tail tissue (single arrowheads in upper panels) and
thickened/split notochord (double arrowheads in lower panels) when compared with wild-type embryos.
TABLE 2
Summary of zebrafish morphologies after mRNA injection or thapsigargin treatment
Zebrafish embryos were microinjected with synthesized mRNA at the 1–2-cell stage or treated with thapsigargin at the 32–64-cell stage. Embryos were observed at 24 hpf
for morphological defects and characterized according to the dorsalization phenotypes C1–C5 (12).
Treatment n C1–C3 C4–C5 Othera Normal
hAHCYL1A (1000 g/ml) 97 42 (43.3%) 12 (12.4%) 43 (44.3%)
zAHCYL1A (1000 g/ml) 84 50 (59.5%) 8 (9.5%) 26 (31.0%)
hAHCY (1000 g/ml) 89 4 (4.5%) 0 (0%) 12 (13.5%) 73 (82.0%)
GFP (1200 g/ml) 130 1 (0.7%) 0 (0%) 7 (5.4%) 122 (93.8%)
Thapsigargin (5 M) 155 5 (3.2%) 118 (76.1%) 32 (20.6%) 0 (0%)
aMorphologies not seen in AHCYL1 microinjections.
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induced dorsalization of zebrafish embryos (Figs. 6–9). These
results are consistent with the notion that AHCYL1 binding
down-regulates the function of IP3R by its competitionwith IP3
for IP3R binding (6).Moreover, AHCYL1 overexpression inhib-
its IP3R-mediated Ca2 release, causing dorsalization, and
AHCYL1 suppression overactivates IP3R-mediated Ca2
release, causing ventralization. Our data, although indirect,
suggest that AHCYL1 behaves as a regulator to control IP3R
activation levels and thus hasmajor impacts on embryogenesis.
We isolated two alternative splice forms of zAHCYL1 differ-
ing only in their N-terminal sequences. Similar alternative
splicing was documented for hAHCYL1 (Fig. 2). The N-termi-
nal hydrophilic domain of AHCYL1 is essential for binding to
the IP3R (6), therefore it is possible that the differences in the
N-terminal of the protein encoded by alternative 5 exons may
alter the binding affinity or specificity of the AHCYL1molecule
to different IP3R isoforms. There are three known isoforms of
IP3R, which differ in their tissue distribution, IP3 sensitivity,
and Ca2 dependence (27). The second AHCY-like molecule,
AHCYL2, has a very similar AHCY-like domain but quite a
distinct N-terminal hydrophilic domain (1, 3). There is no
information on AHCYL2 function or its IP3R binding ability,
but its high structural similarity to AHCYL1 suggests that it has
a similar function. They may represent even further potential
for differential and competitive regulatory binding capacity to
the IP3R isoforms, entirely consistent with the complexity of
regulation of the crucial Ca2 signaling pathway.
The mechanism of AHCYL1-binding to IP3R and the subse-
quent IP3R regulation of Ca2 signaling is likely to be complex: (i)
the binding of AHCYL1 to IP3R requires phosphorylation of
AHCYL1, probably mediated by protein kinases downstream of
intracellular calcium release (e.g. protein kinase C, Ca2/calmod-
ulin-dependent protein kinases, and/or the other protein kinases
concomitantly activated with the inositol phospholipid signaling
pathway), (ii) there is in excess of nonphosphorylated free
AHCYL1within the cytoplasm, (iii) protein phosphatases are also
likely to play a role in maintaining the equilibrium between non-
phosphorylated and phosphorylated AHCYL1, and (iv) these
phosphatasesmust also be regulated within the inositol phospho-
lipid signaling cascades. There are noAHCYL1-negative cell lines
readily available for experimentation.4 This plus these complex
interactions make it difficult to obtain direct evidence for
AHCYL1 function.Weare currently performingexperiments that
will address AHCYL1 function more directly, using cells from
AHCYL1 gene-deletedmice.
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Note Added in Proof—Devogelaere et al. (28) showed recently that
AHCYL1 binds directly to IP3R and inhibits IP3 binding and IP3-
induced Ca2 release.
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